A minimum of 3 years of sustained clinical remission may protect against an increase in disease activity and the development ...

The FDA has agreed to review an application from Roche that seeks approval in the U.S. of obinutuzumab as a treatment for ...

Autoimmune diseases make the immune system attack healthy tissues. These can affect organs like kidneys, leading to ...

The other side of the coin is that a lot of our patients come in, and they already have damage to the kidney because the diagnosis of lupus nephritis is often made after proteinuria has achieved a ...

Lupus is a chronic autoimmune condition that may cause inflammation in one or more organs, such as your kidneys, skin, and heart. Asthma is also a chronic inflammatory health condition ...

Lupus nephritis is a severe form of SLE that can lead to late-stage renal failure and require dialysis or even a kidney replacement in the most severe cases. GSK estimates that around 60% of the ...

The Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for obinutuzumab (Gazyva®) for the treatment of lupus nephritis.  Obinutuzumab is a monoclonal ...

Systemic lupus erythematosus, or lupus, is a complex autoimmune disease in which the immune system mistakenly attacks healthy ...

People with diabetes and high blood pressure are more susceptible to chronic kidney disease. Know treatment options, ...

In standing together, we can ensure that Mercédi’s fight with lupus is not her fight alone. A community mobilised by empathy offers both hope and a tangible path toward recovery. Every effort matters ...

The National Kidney Foundation (NKF) is proud to announce that its KidneyCARE (Community Access to Research Equity)™ Study – ...